Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice  Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine.

Published byJussi Väänänen Modified over 5 years ago

Similar presentations

Presentation on theme: "Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice  Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine."— Presentation transcript:

1 Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice 
Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine A O'Doherty, PhD, MRCP (UK), Silke Collins, MD  Journal of Pain and Symptom Management  Volume 20, Issue 2, Pages (August 2000) DOI: /S (00)

2 Fig. 1 Frequency of breakthrough pains in hospice patients on admission Journal of Pain and Symptom Management  , 87-92DOI: ( /S (00) )

3 Fig. 2 Duration of breakthrough pains in hospice patients on admission
Journal of Pain and Symptom Management  , 87-92DOI: ( /S (00) )

Download ppt "Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice  Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine."

Similar presentations

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.
Prevalence of Breakthrough Cancer Pain: A Systematic Review and a Pooled Analysis of Published Literature  Silvia Deandrea, MD, PhD, Oscar Corli, MD,

Prevalence of Breakthrough Cancer Pain: A Systematic Review and a Pooled Analysis of Published Literature  Silvia Deandrea, MD, PhD, Oscar Corli, MD,
Palliative Sedation at Home for Terminally Ill Children With Cancer

Palliative Sedation at Home for Terminally Ill Children With Cancer
Jane Gibbins, MD, MRCP, Colette M

Jane Gibbins, MD, MRCP, Colette M
An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain  Giovambattista.

An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain  Giovambattista.
Oral Candidosis in Community-Based Patients with Advanced Cancer

Oral Candidosis in Community-Based Patients with Advanced Cancer
Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.
Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment  Katherine Webber, MBBS, MSc, PhD, Andrew.

Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment  Katherine Webber, MBBS, MSc, PhD, Andrew.
The opportunity for collaborative care provision: the presence of nursing home/hospice collaborations in the U.S. states  Susan C. Miller, PhD, Vincent.

The opportunity for collaborative care provision: the presence of nursing home/hospice collaborations in the U.S. states  Susan C. Miller, PhD, Vincent.
Managing the Symptoms of Neuropathic Pain: An Exploration of Patients' Experiences  S. José Closs, BSc, RGN, MPhil, PhD, Vicki Staples, BSc, MSc, Innes.

Managing the Symptoms of Neuropathic Pain: An Exploration of Patients' Experiences  S. José Closs, BSc, RGN, MPhil, PhD, Vicki Staples, BSc, MSc, Innes.
Comparison of Tropisetron and Chlorpromazine Combinations in the Control of Nausea and Vomiting in Patients with Advanced Cancer  Kyriaki Mystakidou,

Comparison of Tropisetron and Chlorpromazine Combinations in the Control of Nausea and Vomiting in Patients with Advanced Cancer  Kyriaki Mystakidou,
Patricia Ann Repar, DMA, Steve Reid, MD, PhD 

Patricia Ann Repar, DMA, Steve Reid, MD, PhD 
Is the Presence of Dyspnea a Risk Factor for Morbidity in Cancer Patients?  Polly Edmonds, MB BS, MRCP, Irene Higginson, BM, BS,MFPHM, PhD, Dan Altmann,

Is the Presence of Dyspnea a Risk Factor for Morbidity in Cancer Patients?  Polly Edmonds, MB BS, MRCP, Irene Higginson, BM, BS,MFPHM, PhD, Dan Altmann,
“Let's Bring Her Home First

“Let's Bring Her Home First
What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study  Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study  Catherine Malia, MSc, Michael I. Bennett, MB, ChB,
Vincent Maida, MD, MSc, BSc, Jason Corban, MD, CM, Hon BSc 

Vincent Maida, MD, MSc, BSc, Jason Corban, MD, CM, Hon BSc 
Use of Ketamine for Ischemic Pain in End-Stage Renal Failure

Use of Ketamine for Ischemic Pain in End-Stage Renal Failure
The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.
Associations Between Objectively Measured Physical Activity and Quality of Life in Cancer Patients With Brain Metastases  Sonya S. Lowe, MD, MSc, Brita.

Associations Between Objectively Measured Physical Activity and Quality of Life in Cancer Patients With Brain Metastases  Sonya S. Lowe, MD, MSc, Brita.
Where Do Cancer Patients Die in Greece

Where Do Cancer Patients Die in Greece

Similar presentations

Ads by Google